UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
FORM 40-F
[X] | Registration statement pursuant to Section 12 of the Securities Exchange Act of 1934 |
| or |
[ ] | Annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 |
For the fiscal year ended | | | Commission File Number | |
____________________
IM Cannabis Corp.
(Exact name of Registrant as specified in its charter)
British Columbia | 2833 | Not Applicable
|
(Province or other jurisdiction of | (Primary Standard Industrial Classification | (I.R.S. Employer |
incorporation or organization) | Code Number) | Identification Number) |
Suite 2300, 550 Burrard Street
Vancouver, British Columbia, Canada V6C 2B5
(416) 256-4202
(Address and telephone number of Registrant's principal executive offices)
____________________
CT Corporation System
1015 15th Street N.W., Suite 1000
Washington, DC 20005
(202) 572-3133
(Name, address (including zip code) and telephone number (including
area code) of agent for service in the United States)
____________________
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common Shares, without par value | IMCC | The NASDAQ Stock Market LLC |
Securities registered pursuant to Section 12(g) of the Act: None.
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
For annual reports, indicate by check mark the information filed with this Form:
[ ] Annual information form | [ ] Audited annual financial statements |
Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report: N/A
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. [ ] Yes [X] No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). [ ] Yes [ ] No
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.
Emerging growth company [X]
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. [ ]
The term "new or revised financial accounting standard" refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
EXPLANATORY NOTE
IM Cannabis Corp. (the "Company" or the "Registrant") is a Canadian issuer eligible to file its registration statement pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), on Form 40-F pursuant to the multi-jurisdictional disclosure system of the Exchange Act. The Company is a "foreign private issuer" as defined in Rule 3b-4 under the Exchange Act. Equity securities of the Company are accordingly exempt from Sections 14(a), 14(b), 14(c), 14(f) and 16 of the Exchange Act pursuant to Rule 3a12-3.
FORWARD LOOKING STATEMENTS
The Exhibits incorporated by reference into this Registration Statement of the Registrant may contain “forward-looking information” or “forward-looking statements” within the meaning of applicable securities laws (collectively referred to herein as “forward-looking statements”). All statements other than statements of fact may be deemed to be forward-looking statements, including statements with regard to expected financial performance, strategy and business conditions. The words “believe”, “plan”, “intend”, “estimate”, “expect”, “anticipate”, “continue”, or “potential”, and similar expressions, as well as future or conditional verbs such as “will”, “should”, “would”, and “could” often identify forward-looking statements. These statements reflect management’s beliefs with respect to future events and are based on information available to management as of the respective dates set forth in the Exhibits incorporated by reference into this Registration Statement, including reasonable assumptions, estimates, internal and external analysis and opinions of management considering its experience, perception of trends, current conditions and expected developments as well as other factors that management believed to be relevant as at the date such statements were made. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated or implied in such forward-looking statements, including, without limitation, those described in the Registrant’s Annual Information Form for the year ended December 31, 2019, attached hereto as Exhibit 99.79.
The Registrant and management caution readers not to place undue reliance on any forward-looking statements, which speak only as of the date made. Although the Registrant believes that the expectations reflected in the forward-looking statements were reasonable as of the time such forward-looking statements were made, it can give no assurance that such expectations will prove to have been correct. The Registrant and management assume no obligation to update or revise them to reflect new events or circumstances except as required by applicable securities laws.
DIFFERENCES IN UNITED STATES AND CANADIAN REPORTING PRACTICES
The Registrant is permitted, under a multijurisdictional disclosure system adopted by the United States, to prepare this report in accordance with Canadian disclosure requirements, which are different from those of the United States. The Registrant prepares its consolidated financial statements, which are filed with this report on Form 40-F in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board, and the audit is subject to Canadian auditing and auditor independence standards.
PRINCIPAL DOCUMENTS
In accordance with General Instruction B.(1) of Form 40-F, the Registrant hereby incorporates by reference Exhibits 99.1 through 99.104 inclusive, as set forth in the Exhibit Index attached hereto.
In accordance with General Instruction D.(9) of Form 40-F, the Registrant has filed the written consent of certain experts named in the foregoing Exhibits as Exhibit 99.105, as set forth in the Exhibit Index attached hereto.
TAX MATTERS
Purchasing, holding, or disposing of securities of the Registrant may have tax consequences under the laws of the United States and Canada that are not described in this Registration Statement on Form 40-F.
DESCRIPTION OF COMMON SHARES
The required disclosure is included under the heading “Description of Capital Structure” in the Registrant’s Annual Information Form for the year ended December 31, 2019, attached hereto as Exhibit 99.79.
OFF-BALANCE SHEET ARRANGEMENTS
The Registrant has no off-balance sheet arrangements.
CURRENCY
Unless otherwise indicated, all dollar amounts in this Registration Statement on Form 40-F are in United States dollars. The exchange rate of Canadian dollars into United States dollars, on December 31, 2019, based upon the daily exchange rate as quoted by the Bank of Canada was U.S.$1.00 = Cdn.$1.2988.
CONTRACTUAL OBLIGATIONS
The following table lists, as of December 31, 2019, information with respect to the Registrant's known contractual obligations:
| Payments due by period | | | |
| | | |
| | | | | Less than | | | | | | | | | More than | |
Contractual Obligations | | Total ($) | | | 1 year ($) | | | 1-3 years ($) | | | 3-5 years ($) | | | 5 years ($) | |
| | | | | | | | | | | | | | | |
Operating Lease Obligations (Undiscounted) | | 1,073 | | | 176 | | | 265 | | | 171 | | | 461 | |
| | | | | | | | | | | | | | | |
Purchase Obligations(1) | | 764 | | | 764 | | | - | | | - | | | - | |
| | | | | | | | | | | | | | | |
Total(2)(3) | $ | 1,837 | | | 940 | | | 265 | | | 171 | | | 461 | |
(1) Purchase commitments are obligations under purchase agreements or purchase orders not yet fulfilled that are non-cancelable.
(2) The obligation amount does not include an amount of $202 of employee benefit liability, net. See also Note 13 to the Consolidated Financial Statements as of December 31, 2019.
(3) The obligation amount does not include an amount of $152 of non-current warrants liability as of December 31, 2019, which settlement is in the company’s common stock.
UNDERTAKING
The Registrant undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to the securities registered pursuant to Form 40-F or transactions in said securities.
CONSENT TO SERVICE OF PROCESS
The Registrant has concurrently filed a Form F-X in connection with the class of securities to which this Registration Statement relates.
Any change to the name or address of the Registrant's agent for service shall be communicated promptly to the Commission by amendment to the Form F-X referencing the file number of the Registrant.
SIGNATURES
Pursuant to the requirements of the Exchange Act, the Registrant certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized.
| | IM Cannabis Corp. |
| | |
| | |
| By: | /s/ Oren Shuster |
| | Name: Oren Shuster |
Date: February 12, 2021 | | Title: Chief Executive Officer and Director |
EXHIBIT INDEX
The following documents are being filed with the Commission as Exhibits to this Registration Statement:
Exhibit | Description |
99.1 | Management's Discussion and Analysis of IM Cannabis Corp. for the year and three months ended December 31, 2019 |
99.2 | Audited Financial Statements of IM Cannabis Corp. for the year ended December 31, 2019 |
99.3 | News Release dated January 6, 2020 |
99.4 | News Release dated January 7, 2020 |
99.5 | Notice of Annual General Meeting of Shareholders dated January 10, 2020 |
99.6 | News Release dated January 28, 2020 |
99.7 | Notice of Change of Auditor dated January 19, 2020 |
99.8 | Letter from Successor Auditor dated January 22, 2020 |
99.9 | Letter from Former Auditor dated January 20, 2020 |
99.10 | News Release dated January 30, 2020 |
99.11 | Form of Proxy of IM Cannabis Corp. |
99.12 | Notice of Annual General Meeting of Shareholders dated February 18, 2020 |
99.13 | Management Information Circular dated February 18, 2020 |
99.14 | News Release dated March 17, 2020 |
99.15 | News Release dated March 23, 2020 |
99.16 | News Release dated March 30, 2020 |
99.17 | News Release dated March 31, 2020 |
99.18 | News Release dated April 2, 2020 |
99.19 | News Release dated April 8, 2020 |
99.20 | News Release dated April 13, 2020 |
99.21 | News Release dated April 16, 2020 |
99.22 | News Release dated April 20, 2020 |
99.23 | News Release dated April 21, 2020 |
99.24 | Certification of Annual Filings Following an Initial Public Offering, Reverse Takeover or Becoming a Non-Venture Issuer in connection with the filing of the AIF, annual financial statements and annual MD&A by CEO dated April 21, 2020 |
99.25 | Certification of Annual Filings Following an Initial Public Offering, Reverse Takeover or Becoming a Non-Venture Issuer in connection with the filing of the AIF, annual financial statements and annual MD&A by CFO dated April 21, 2020 |
99.26 | News Release dated April 27, 2020 |
99.27 | News Release dated May 7, 2020 |
99.28 | News Release dated May 12, 2020 |
99.29 | News Release dated May 14, 2020 |
99.30 | News Release dated May 19, 2020 |
99.31 | News Release dated May 26, 2020 |
99.32 | News Release dated May 27, 2020 |
99.33 | News Release dated June 4, 2020 |
99.34 | News Release dated June 5, 2020 |
99.35 | Unaudited Interim Condensed Consolidated Financial Statements of IM Cannabis Corp. for the three-month period ended March 31, 2020 |
99.36 | Certification of Interim Filings Venture Issuer Basic Certificate of IM Cannabis Corp. in connection with the filing of the interim financial report and interim MD&A by CFO dated June 5, 2020 |
99.37 | Certification of Interim Filings Venture Issuer Basic Certificate of IM Cannabis Corp. in connection with the filing of the interim financial report and interim MD&A by CEO dated June 5, 2020 |
99.38 | Management's Discussion and Analysis of IM Cannabis Corp. for the three-month period ended March 31, 2020 |
99.39 | News Release dated June 10, 2020 |
99.40 | News Release dated June 15, 2020 |
99.41 | News Release dated June 18, 2020 |
99.42 | News Release dated June 22, 2020 |
99.43 | News Release dated June 24, 2020 |
99.44 | News Release dated June 30, 2020 |
99.45 | News Release dated July 6, 2020 |
99.46 | News Release dated July 15, 2020 |
99.47 | News Release dated July 21, 2020 |
99.48 | News Release dated July 27, 2020 |
99.49 | Certification of Interim Filings Venture Issuer Basic Certificate of IM Cannabis Corp. in connection with the filing of the interim financial report and interim MD&A by CEO dated August 26, 2020 |
99.50 | Management's Discussion and Analysis of IM Cannabis Corp. for the three and six-month period ended June 30, 2020 |
99.51 | Unaudited Interim Condensed Consolidated Financial Statements of IM Cannabis Corp. for the three and six-month periods ended June 30, 2020 |
99.52 | Certification of Interim Filings Venture Issuer Basic Certificate of IM Cannabis Corp. in connection with the filing of the interim financial report and interim MD&A by CFO dated August 26, 2020 |
99.53 | News Release dated August 26, 2020 |
99.54 | News Release dated September 15, 2020 |
99.55 | News Release dated September 23, 2020 |
99.56 | Notice of Special Meeting of Shareholders dated October 2, 2020 |
99.57 | News Release dated October 6, 2020 |
99.58 | News Release dated October 7, 2020 |
99.59 | News Release dated October 8, 2020 |
99.60 | News Release dated November 16, 2020 |
99.61 | Form of Proxy of IM Cannabis Corp. for Special Meeting to be held on December 16, 2020 |
99.62 | Notice of Special Meeting of Shareholders dated December 16, 2020 |
99.63 | Financial Statements Request Form |
99.64 | Notice of Special Meeting of Shareholders and Management Information Circular dated November 12, 2020 |
99.65 | Certification of Interim Filings Venture Issuer Basic Certificate of IM Cannabis Corp. in connection with the filing of the interim financial report and interim MD&A by CFO dated November 27, 2020 |
99.66 | Certification of Interim Filings Venture Issuer Basic Certificate of IM Cannabis Corp. in connection with the filing of the interim financial report and interim MD&A by CEO dated November 27, 2020 |
99.67 | Management’s Discussion and Analysis of IM Cannabis Corp. for the three and nine-month period ended September 30, 2020 |
99.68 | Unaudited Interim Condensed Consolidated Financial Statements of IM Cannabis Corp. for the three and nine-month periods ended September 30, 2020 |
99.69 | News Release dated November 27, 2020 |
99.70 | Code of Conduct |
99.71 | News Release dated December 17, 2020 |
99.72 | News Release dated December 30, 2020 |
99.73 | Arrangement Agreement dated December 30, 2020 |
99.74 | Material Change Report dated January 8, 2021 |
99.75 | Form 45-102F1 dated January 11, 2021 |
99.76 | News Release dated January 12, 2021 |
99.77 | Amending Agreement dated January 22, 2021 |
99.78 | News Release dated January 26, 2021 |
99.79 | Annual Information Form dated January 27, 2021 |
99.80 | Certification of Annual Filings of IM Cannabis Corp. in connection with the filing of the voluntarily filed AIF by the CFO dated January 29, 2021 |
99.81 | Certification of Annual Filings of IM Cannabis Corp. in connection with the filing of the voluntarily filed AIF by the CEO dated January 29, 2021 |
99.82 | Notice Declaring Intention to be Qualified under National Instrument 44-101 Short Form Prospectus Distributions dated January 29, 2021 |
99.83 | News Release dated February 10, 2021 |
99.84 | Form 7 Monthly Progress Report dated January 8, 2020 |
99.85 | Form 7 Monthly Progress Report dated February 7, 2020 |
99.86 | Form 10 Notice of Proposed Transaction dated February 24, 2020 |
99.87 | Form 7 Monthly Progress Report dated March 6, 2020 |
99.88 | Form 7 Monthly Progress Report dated April 7, 2020 |
99.89 | Form 7 Monthly Progress Report dated May 6, 2020 |
99.90 | Form 7 Monthly Progress Report dated June 5, 2020 |
99.91 | Form 5 Quarterly Listing Statement dated June 5, 2020 |
99.92 | Form 11 Notice of Proposed Stock Option Grant dated June 11, 2020 |
99.93 | Form 7 Monthly Progress Report dated July 8, 2020 |
99.94 | Form 11 Notice of Proposed Stock Option Grant or Amendment dated August 4, 2020 |
99.95 | Form 7 Monthly Progress Report dated August 10, 2020 |
99.96 | Form 5 Quarterly Listing Statement dated September 8, 2020 |
99.97 | Form 7 Monthly Progress Report dated September 8, 2020 |
99.98 | Form 7 Monthly Progress Report dated October 6, 2020 |
99.99 | Form 7 Monthly Progress Report dated December 7, 2020 |
99.100 | Form 5 Quarterly Listing Statement dated December 7, 2020 |
99.101 | Form 11 Notice of Proposed Stock Option Grant or Amendment dated December 17, 2020 |
99.102 | Form 7 Monthly Progress Report dated January 8, 2021 |
99.103 | Form 9 Notice of Issuance of Proposed Issuance of Listed Securities dated January 11, 2021 |
99.104 | Form 7 Monthly Progress Report dated February 5, 2021 |
99.105 | Consent of Kost Forer Gabbay & Kasierer |